These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3698043)

  • 1. Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCN.
    Wotring LL; Crabtree GW; Edwards NL; Parks RE; Townsend LB
    Cancer Treat Rep; 1986 Apr; 70(4):491-7. PubMed ID: 3698043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen.
    Schilcher RB; Haas CD; Samson MK; Young JD; Baker LH
    Cancer Res; 1986 Jun; 46(6):3147-51. PubMed ID: 3698029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of triciribine is necessary for activity against HIV type 1.
    Ptak RG; Borysko KZ; Porcari AR; Buthod JL; Holland LE; Shipman C; Townsend LB; Drach JC
    AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1315-22. PubMed ID: 9788672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)- pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine on the viability and cell cycle distribution of L1210 cells in vitro.
    Wotring LL; Passiatore JE; Roti Roti JL; Hudson JL; Townsend LB
    Cancer Res; 1985 Dec; 45(12 Pt 1):6355-61. PubMed ID: 4063986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
    Moore EC; Hurlbert RB; Boss GR; Massia SP
    Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis.
    Moore EC; Hurlbert RB; Massia SP
    Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials.
    Powis G; Basseches PJ; Kroschel DM; Richardson RL; O'Connell MJ; Kvols LK
    Cancer Treat Rep; 1986 Mar; 70(3):359-62. PubMed ID: 3955547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanisms of inhibition of DNA synthesis by triciribine.
    Wotring LL; Townsend LB; Jones LM; Borysko KZ; Gildersleeve DL; Parker WB
    Cancer Res; 1990 Aug; 50(16):4891-9. PubMed ID: 2379153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies.
    Narayanan S; Shandil RK; Ahuja VK; Shanmugam SS; Mahesh K U H; Ramesh N; Surendran N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122714. PubMed ID: 33962189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of tricyclic nucleoside 5'-phosphate in model systems of human ovarian cancer.
    Behrens BC; Hamilton TC; Louie KG; Grotzinger KR; McKoy WM; Tsuruo T; Young RC; Ozols RF
    Invest New Drugs; 1986; 4(4):295-304. PubMed ID: 3583641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
    Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
    Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral activity of 2-substituted analogs of triciribine.
    Porcari AR; Ptak RG; Borysko KZ; Breitenbach JM; Drach JC; Townsend LB
    Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2171-93. PubMed ID: 14714765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE; Selner M; Phillips JR
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell line.
    Chaney SG; Gibbons GR; Wyrick SD; Podhasky P
    Cancer Res; 1991 Feb; 51(3):969-73. PubMed ID: 1988140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat.
    Basseches PJ; Powis G
    Cancer Res; 1984 Sep; 44(9):3672-8. PubMed ID: 6540141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversed-phase high-performance liquid chromatographic determination of tricyclic nucleoside and tricyclic nucleoside 5'-phosphate in biological specimens.
    Schilcher RB; Young JD; Baker LH
    J Chromatogr; 1985 Jan; 337(1):55-62. PubMed ID: 3980657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane.
    Berndt N; Yang H; Trinczek B; Betzi S; Zhang Z; Wu B; Lawrence NJ; Pellecchia M; Schönbrunn E; Cheng JQ; Sebti SM
    Cell Death Differ; 2010 Nov; 17(11):1795-804. PubMed ID: 20489726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay of the antineoplastic agent tricyclic nucleoside 5'-phosphate and its disposition in rabbit.
    Basseches PJ; Durski A; Powis G
    J Chromatogr; 1982 Dec; 233():227-34. PubMed ID: 7161335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.